Recent Updates
Recently added Catalysts
ECOR Positive Sentiment

electroCore to Participate at 13th Annual LD Micro Invitational XIII

Tuesday, May 23, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: electroCore, Inc. announced that CEO Dan Goldberger will present at the 13th Annual LD Micro Invitational XIII in Los Angeles from June 6-8, 2023. The event will be livestreamed for virtual viewers. electroCore is focused on the commercialization of medical devices based on their non-invasive vagus nerve stimulation technology to improve health and wellbeing. This participation showcases the company's commitment to innovation and engagement within the bioelectronic medicine industry.
Price reaction · baseline $5.55 (2023-05-22 close) · hit after-hours · 1 other ECOR headline(s) in the window, move may be shared
day 0 close · peak
+1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • electroCore is participating in a significant industry event.
  • The presentation could enhance visibility and networking opportunities.
  • The company's focus on non-invasive technology aligns with current health trends.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will present at the 13th Annual LD Micro Invitational XIII in Los Angeles, California from June 6-8, 2023.
LD Micro Invitational XIII:
Date: Tuesday, June 6, 2023
Virtual viewers: Livestream
For more information regarding the Invitational and to register to watch the presentation live, please visit the conference page here.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

When is the LD Micro Invitational XIII scheduled?

The LD Micro Invitational XIII is set for June 6-8, 2023.

Who will present at the LD Micro Invitational XIII?

Dan Goldberger, CEO of electroCore, will present at the event.

What technology does electroCore focus on?

electroCore specializes in non-invasive vagus nerve stimulation technology.

How can I watch the LD Micro Invitational live?

You can livestream the event by registering on the conference page.

What is electroCore's mission?

electroCore aims to enhance health through bioelectronic medicine solutions.

ShareAdd on Google
Tags: ECOR Viatris Investor Conferences Healthcare electroCore bioelectronic medicine non-invasive technology LD Micro Invitational nVNS
Last updated: May 23, 2023

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~7 mo
High dilution risk
Lead asset
GammaCorePhase 2
Chronic Cluster Headache →